Latest reported dividend
Not available
MRK · NYSE
Pharmaceutical Preparations
Not available
Not available
Not reported
44.8%
66.1%
These ratios relate cash dividends paid by the company to its earnings and free cash flow for the stated period. They are not dividend yields or measures of a guaranteed future payout.
No matching dividend events have been collected. This does not establish that the company pays no dividend.
| Reporting period | Measure | USD millions | Filing |
|---|---|---|---|
| Dec 31, 2025From Jan 1, 2025 | Operating cash flow | 16,472.0 | SEC filingFeb 24, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Net income | 18,254.0 | SEC filingFeb 24, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Common-stock cash dividends | 8,176.0 | SEC filingFeb 24, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Capital expenditures (PP&E) | 4,112.0 | SEC filingFeb 24, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Operating cash flow | 21,468.0 | SEC filingFeb 24, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Net income | 17,117.0 | SEC filingFeb 24, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Common-stock cash dividends | 7,840.0 | SEC filingFeb 24, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Capital expenditures (PP&E) | 3,372.0 | SEC filingFeb 24, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Operating cash flow | 13,006.0 | SEC filingFeb 24, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Net income | 365.0 | SEC filingFeb 24, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Common-stock cash dividends | 7,445.0 | SEC filingFeb 24, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Capital expenditures (PP&E) | 3,863.0 | SEC filingFeb 24, 2026 |
| Dec 31, 2022From Jan 1, 2022 | Operating cash flow | 19,095.0 | SEC filingFeb 25, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Net income | 14,519.0 | SEC filingFeb 25, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Common-stock cash dividends | 7,012.0 | SEC filingFeb 25, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Capital expenditures (PP&E) | 4,388.0 | SEC filingFeb 25, 2025 |
| Dec 31, 2021From Jan 1, 2021 | Net income | 13,049.0 | SEC filingFeb 26, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Common-stock cash dividends | 6,610.0 | SEC filingFeb 26, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Capital expenditures (PP&E) | 4,448.0 | SEC filingFeb 26, 2024 |
| Dec 31, 2020From Jan 1, 2020 | Operating cash flow | 10,253.0 | SEC filingFeb 25, 2021 |
A higher payout ratio can reflect a larger dividend, lower earnings, or both. Capital spending also affects the FCF denominator. The accounting context matters, especially for financial firms, REITs, and business development companies.
Understand cash payout ratios · Regular vs. special dividendsSource: collected SEC filings. USYieldHub is not affiliated with or endorsed by the SEC or this issuer. Coverage is incomplete; amounts may be unadjusted for splits.